Single-Cell Genomics of Cardiovascular Disease: Deciphering Cellular Complexity in Heart Failure and Vascular Pathology
Single-Cell Genomics of Cardiovascular Disease: Deciphering Cellular Complexity in Heart Failure and Vascular Pathology
Authors
Tom and Spike
Abstract
Cardiovascular disease remains the leading cause of mortality worldwide, claiming over 17 million lives annually and presenting an enormous burden on healthcare systems. The heart and vasculature comprise intricate cellular ecosystems with remarkable heterogeneity that has only recently been revealed through single-cell RNA sequencing technologies. This comprehensive review synthesizes how scRNA-seq has transformed our understanding of cardiovascular biology and disease, revealing the cellular composition of the heart, the mechanisms of cardiac development and regeneration, and the pathological processes driving heart failure, atherosclerosis, and arrhythmias. We examine the discovery of novel cell populations including resident cardiac macrophages, fibroblast subsets with distinct functions, and previously unrecognized vascular cell types. We explore how single-cell approaches have characterized cellular responses to myocardial infarction, revealed the mechanisms of cardiac fibrosis, and identified the cellular basis of arrhythmogenic substrates. Furthermore, we discuss the integration of single-cell multi-omics and spatial transcriptomics, which have provided unprecedented views of cardiac tissue organization and intercellular communication. The review concludes with perspectives on how single-cell technologies are enabling precision cardiology and accelerating the development of novel therapeutics for cardiovascular disease.
Keywords: single-cell RNA sequencing, cardiovascular disease, heart failure, cardiomyocytes, cardiac fibroblasts, atherosclerosis, spatial transcriptomics, precision cardiology
1. Introduction
Cardiovascular disease (CVD) encompasses a spectrum of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and valvular diseases. Despite remarkable advances in prevention and treatment over the past half-century, CVD remains the leading global cause of death, responsible for approximately 32% of all deaths worldwide. The burden of CVD is expected to grow with aging populations and increasing prevalence of risk factors including obesity, diabetes, and hypertension.
The heart is a complex organ composed of multiple interacting cell types that must coordinate their functions to maintain continuous pumping throughout a lifetime. Cardiomyocytes, the contractile cells of the heart, work in concert with fibroblasts, endothelial cells, smooth muscle cells, immune cells, and others to maintain cardiac structure, function, and repair. Traditionally, these cell populations were defined based on limited marker proteins and histological appearance, masking important heterogeneity within each population that may have functional significance.
The advent of single-cell RNA sequencing has revolutionized our understanding of cardiac cellular complexity. Beginning with seminal studies in 2016-2017 that produced the first single-cell atlases of the mammalian heart, scRNA-seq has revealed remarkable heterogeneity within all major cardiac cell populations. These discoveries have transformed our understanding of cardiac development, physiology, and pathology, revealing new cellular players in disease processes and identifying novel therapeutic targets.
This comprehensive review synthesizes the major advances in single-cell cardiovascular research. We begin by examining the cellular atlas of the healthy heart, revealing the diverse cell populations that comprise this organ. We then explore how single-cell approaches have illuminated our understanding of specific cardiovascular diseases, including heart failure, myocardial infarction, atherosclerosis, and arrhythmias. We discuss the integration of multi-omics and spatial approaches, which provide increasingly comprehensive views of cardiac biology. Finally, we consider how single-cell technologies are enabling precision cardiology and accelerating therapeutic development.
2. Cellular Atlas of the Healthy Heart
2.1 Cardiomyocyte Diversity and Maturation
Cardiomyocytes, the contractile cells of the heart, have traditionally been categorized into atrial and ventricular types, with some recognition of specialized pacemaker and conduction system cells. Single-cell studies have revealed remarkable heterogeneity within cardiomyocyte populations, with distinct transcriptional programs correlating with anatomical location, functional specialization, and developmental stage.
scRNA-seq studies have identified at least six major cardiomyocyte populations in the adult mammalian heart, including atrial and ventricular cardiomyocytes, pacemaker cells of the sinoatrial node, atrioventricular node cells, His-Purkinje system cells, and cardiomyocytes with embryonic-like transcriptional programs. Each population expresses a distinctive set of genes encoding ion channels, contractile proteins, and signaling molecules that underlie their functional properties.
The discovery of cardiomyocytes with embryonic-like gene expression programs in adult hearts has been particularly intriguing. These cells, sometimes termed "cardiomyocyte progenitors" or "juvenile cardiomyocytes," express genes associated with cell cycle activity, embryonic development, and metabolic flexibility. While their true potential for proliferation and regeneration remains debated, they represent a target population that might be harnessed for cardiac repair.
Single-cell studies of human cardiac development have revealed the transcriptional programs that drive cardiomyocyte maturation from fetal to adult states. These programs involve dramatic metabolic shifts from glycolysis to fatty acid oxidation, changes in calcium handling proteins, and alterations in contractile protein isoforms. Understanding these maturation programs has important implications for stem cell-derived cardiomyocytes, which often exhibit immature phenotypes that limit their therapeutic utility.
2.2 Cardiac Fibroblast Heterogeneity
Cardiac fibroblasts, once considered a homogeneous population of matrix-producing cells, have been revealed by scRNA-seq to comprise multiple functionally distinct subsets. Early single-cell studies of the mouse heart identified at least two major fibroblast populations: fibroblasts in healthy myocardium and activated fibroblasts (myofibroblasts) in injured or diseased hearts.
More recent studies with improved resolution have identified additional fibroblast diversity, including subsets that differ in their expression of extracellular matrix genes, growth factors, and signaling molecules. Some fibroblast subsets express genes associated with angiogenesis and may support blood vessel formation, while others express genes involved in immune cell recruitment and inflammation. This functional diversity suggests that fibroblasts play more nuanced roles in cardiac homeostasis and repair than previously appreciated.
Perhaps the most intriguing discovery from cardiac fibroblast single-cell studies is the identification of fibroblast populations that express markers associated with other cell lineages, suggesting fibroblast plasticity and potential for transdifferentiation. Some cardiac fibroblasts express genes characteristic of osteoblasts, chondrocytes, or even cardiomyocytes, raising the possibility that fibroblasts could be reprogrammed for therapeutic purposes. This plasticity represents an exciting target for developing novel approaches to cardiac repair.
2.3 Vascular and Endothelial Cell Diversity
The cardiac vasculature comprises multiple endothelial cell populations with distinct functional properties. Single-cell studies have identified endothelial cells from arteries, veins, capillaries, and lymphatic vessels, each with characteristic gene expression profiles. Endothelial cells from different vascular beds show differential expression of genes involved in angiogenesis, permeability, and immune cell trafficking.
Cardiac lymphatic endothelial cells, identified by expression of PROX1, LYVE1, and other lymphatic markers, play important roles in fluid balance and immune cell trafficking. Single-cell studies have revealed that these cells are more abundant and diverse than previously appreciated, with subsets that differ in their gene expression programs and potentially in their functions. The manipulation of cardiac lymphatic function represents an emerging therapeutic strategy for reducing edema and inflammation after myocardial infarction.
Pericytes and vascular smooth muscle cells, which surround blood vessels and regulate tone and structure, also exhibit heterogeneity revealed by single-cell analysis. Pericytes from different vascular beds show differential expression of genes involved in angiogenesis and extracellular matrix production, while smooth muscle cells from arteries versus veins have distinct contractile and synthetic phenotypes. This diversity has important implications for understanding vascular pathology and developing targeted therapies.
2.4 Cardiac Immune Cell Landscape
The immune cell repertoire of the healthy heart is far more complex than previously appreciated. Single-cell studies have identified multiple resident macrophage populations that differ in their ontogeny, surface markers, and functional properties. These include embryonic-derived macrophages that self-renew locally and monocyte-derived macrophages that are recruited during inflammation.
Resident cardiac macrophages have been categorized based on expression of CCR2, LY6C, MHC class II, and other markers into functional subsets. CCR2- macrophages are predominantly tissue-resident, exhibit homeostatic functions including clearance of debris and support of cardiomyocytes, and express genes involved in tissue repair. CCR2+ macrophages are more numerous during inflammation, express proinflammatory cytokines, and may contribute to tissue injury when excessively activated.
Beyond macrophages, single-cell studies have revealed diverse populations of other immune cells in the healthy heart, including dendritic cells, mast cells, innate lymphoid cells, and small populations of T cells and B cells. The baseline presence of these immune cells suggests that immune surveillance is an ongoing process even in healthy hearts, potentially protecting against infection and injury while maintaining tissue homeostasis.
3. Cellular Responses to Myocardial Infarction
3.1 Early Inflammatory Response
Myocardial infarction (MI), the death of cardiomyocytes due to prolonged ischemia, triggers a complex cascade of cellular responses that determine infarct healing, remodeling, and ultimately cardiac function. Single-cell studies have provided unprecedented insights into the temporal dynamics and cellular composition of the post-infarction response.
The earliest phase after MI is dominated by a massive inflammatory response, with rapid recruitment of neutrophils and monocytes to the infarct zone. scRNA-seq studies of mouse and human post-MI hearts have revealed remarkable heterogeneity within these recruited immune cells. Neutrophils exhibit distinct activation states, including proinflammatory subsets that produce cytokines and chemokines, and subsets specialized for neutrophil extracellular trap (NET) formation that may contribute to no-reflow phenomena and microvascular obstruction.
Monocytes recruited after MI rapidly differentiate into macrophages with diverse functional properties. Single-cell trajectory analysis has revealed the continuum of monocyte-to-macrophage differentiation, with intermediate cells exhibiting hybrid phenotypes. The macrophages that populate the infarct show considerable diversity, with subsets expressing proinflammatory genes (TNF, IL1B), anti-inflammatory genes (IL10, TGFB1), or pro-reparative genes (growth factors, matrix proteins).
The balance between proinflammatory and reparative macrophage populations critically influences infarct healing and cardiac remodeling. Single-cell studies have shown that this balance shifts over time, with early dominance of proinflammatory macrophages giving way to reparative populations. The timing and coordination of this transition influence scar formation, adverse remodeling, and ultimately the development of heart failure.
3.2 Fibroblast Activation and Fibrosis
Fibrosis, the excessive deposition of extracellular matrix by activated fibroblasts, is a hallmark of the post-MI heart and a major contributor to heart failure development. Single-cell studies have revealed the dynamics of fibroblast activation after MI, identifying intermediate states and regulatory factors that control the transition to myofibroblasts.
Fibroblast activation after MI follows a stereotypical trajectory revealed by pseudotime analysis of single-cell data. Quiescent fibroblasts in healthy myocardium first acquire a "primed" state characterized by expression of immediate early genes and signaling molecules. These primed fibroblasts then differentiate into myofibroblasts that express contractile proteins (ACTA2, TAGLN) and extracellular matrix genes (COL1A1, COL3A1). A subset of these myofibroblasts may persist chronically, driving ongoing fibrosis and adverse remodeling.
Single-cell studies have identified key signaling pathways that drive fibroblast activation, including TGF-β, Wnt, and mechanical signaling pathways. The integration of snRNA-seq with snATAC-seq has revealed the epigenetic changes that accompany fibroblast activation, opening opportunities for epigenetic therapies to modulate fibrosis. Perhaps most excitingly, some activated fibroblasts show potential for reversion to quiescent states, suggesting that established fibrosis might be reversible.
The discovery of fibroblast heterogeneity has important therapeutic implications. Rather than viewing all activated fibroblasts as detrimental, single-cell data reveal subsets that may be beneficial (producing matrix for scar formation to prevent rupture) or detrimental (producing excessive matrix that impairs function). Therapies that selectively target detrimental fibroblast subsets while sparing beneficial ones could improve healing while reducing adverse remodeling.
3.3 Cardiomyocyte Response and Regeneration
Adult mammalian cardiomyocytes have very limited capacity for proliferation and regeneration, contributing to permanent loss of contractile mass after MI. Single-cell studies have characterized the transcriptional responses of surviving cardiomyocytes after MI, revealing adaptive responses that maintain function and potential targets for enhancing regeneration.
Cardiomyocytes bordering the infarct (border zone cardiomyocytes) exhibit distinct transcriptional programs compared to remote cardiomyocytes. These cells show activation of fetal gene programs (NPPA, NPPB), stress response pathways, and metabolic adaptations. While some of these changes may be adaptive (maintaining contractile function under stress), others may be maladaptive (contributing to arrhythmogenesis or apoptosis).
Border zone cardiomyocytes show evidence of partial dedifferentiation, expressing genes characteristic of immature cardiomyocytes. This dedifferentiated state may represent an attempt to re-enter the cell cycle, although full proliferation is typically blocked by multiple mechanisms. The factors that prevent cardiomyocyte proliferation in adult mammals, including cell cycle inhibitors and epigenetic barriers, have been identified through single-cell studies comparing regenerative (neonatal, zebrafish) and non-regenerative (adult mammalian) hearts.
The comparison of regenerative and non-regenerative species at single-cell resolution has revealed key differences in cardiomyocyte responses to injury. Regenerative species show activation of cardiomyocyte proliferation, resolution of inflammation, and organized scar formation, while non-regenerative species show limited proliferation, persistent inflammation, and disorganized fibrosis. These differences identify targets for enhancing regeneration in human hearts.
4. Heart Failure: Cellular Mechanisms and Therapeutic Targets
4.1 Cellular Remodeling in Heart Failure
Heart failure represents the common endpoint of multiple cardiovascular insults, characterized by impaired cardiac output and fluid retention. Single-cell studies of failing human hearts have revealed complex cellular remodeling involving all major cardiac cell types.
Cardiomyocytes in failing hearts show dramatic transcriptional reprogramming, with downregulation of genes involved in calcium handling, contractility, and energy production, and upregulation of stress response and fetal genes. These changes correlate with impaired contractility and contribute to the progressive nature of heart failure. The heterogeneity of cardiomyocyte responses, with some cells more severely affected than others, may contribute to the heterogeneous performance of myocardial regions in failing hearts.
Cardiac fibroblasts in failing hearts show persistent activation, with continued expression of extracellular matrix genes driving ongoing fibrosis. Single-cell studies have identified specific fibroblast subsets that are expanded in heart failure, expressing genes that correlate with fibrosis severity and adverse outcomes. The signals that maintain fibroblast activation in chronic heart failure, including mechanical stress, neurohormonal activation, and inflammation, have been elucidated through single-cell approaches.
The vasculature undergoes significant remodeling in heart failure, with rarefaction of capillaries contributing to ischemia and dysfunction. Single-cell studies have revealed that endothelial cells in failing hearts show activation of inflammatory pathways, impaired angiogenic capacity, and increased expression of adhesion molecules that promote leukocyte infiltration. Pericytes and smooth muscle cells also show altered phenotypes that contribute to vascular rarefaction and increased stiffness.
4.2 Inflammation and Immune Cell Dysregulation
Chronic low-grade inflammation is a hallmark of heart failure, contributing to disease progression and poor outcomes. Single-cell studies have characterized the immune cell landscape of failing hearts, revealing persistent activation of both innate and adaptive immune responses.
Macrophages in failing hearts show persistent activation, with expansion of proinflammatory subsets expressing TNF, IL1B, and other inflammatory mediators. These cells may contribute to ongoing cardiomyocyte dysfunction and death. At the same time, reparative macrophage subsets are relatively deficient, impairing resolution of inflammation and tissue repair.
T cells are expanded in failing hearts, with particular increases in cytotoxic CD8+ T cells and proinflammatory Th17 cells. Single-cell TCR sequencing has revealed that these T cells are oligoclonal, suggesting antigen-specific responses, potentially to cardiac antigens exposed or modified during injury. Regulatory T cells, which normally limit inflammation, are relatively deficient or dysfunctional, contributing to unchecked inflammation.
B cells and plasma cells are also present in failing hearts, producing antibodies that may contribute to immune-mediated injury. Single-cell BCR sequencing has revealed autoantibody production against cardiac proteins including myosin and troponin, suggesting autoimmune mechanisms in heart failure pathogenesis. These findings have raised interest in immunomodulatory therapies for heart failure.
4.3 Cell-Cell Communication Networks
The integration of single-cell data with computational analysis of ligand-receptor interactions has revealed complex communication networks between cardiac cell types in heart failure. These networks involve multiple signaling pathways that coordinate the responses of different cell populations to stress and injury.
Macrophage-cardiomyocyte communication through cytokines including TNF and IL1β contributes to cardiomyocyte dysfunction and death. Fibroblast-cardiomyocyte communication through TGF-β and other factors promotes fibrosis and stiffness. Endothelial-immune cell interactions through adhesion molecules and chemokines perpetuate inflammation.
Perhaps most interestingly, single-cell studies have revealed that these communication networks are dysregulated in heart failure, with excessive activation of pathogenic pathways and deficiency of protective pathways. Restoring normal communication between cell types represents an emerging therapeutic strategy, with approaches targeting specific ligand-receptor pairs showing promise in preclinical models.
5. Atherosclerosis and Vascular Disease
5.1 Cellular Landscape of Atherosclerotic Plaques
Atherosclerosis, the buildup of plaques in arterial walls, underlies most cardiovascular diseases including myocardial infarction and stroke. Single-cell studies of human and mouse atherosclerotic plaques have revealed remarkable cellular complexity that drives plaque initiation, progression, and rupture.
The core cellular components of plaques include macrophage-derived foam cells (lipid-laden macrophages), smooth muscle cells, T cells, and endothelial cells. Single-cell studies have revealed extensive heterogeneity within each of these populations, with subsets that may have opposing effects on plaque stability.
Macrophages in plaques show remarkable diversity, with subsets exhibiting inflammatory, reparative, lipid-handling, and proliferative phenotypes. Inflammatory macrophages express TNF, IL1B, and other cytokines that promote inflammation and tissue damage. Reparative macrophages express factors that promote resolution of inflammation and tissue repair. Lipid-handling macrophages express genes involved in cholesterol uptake and efflux, determining whether lipid accumulates as foam cells or is cleared.
5.2 Smooth Muscle Cell Plasticity
Vascular smooth muscle cells (VSMCs) in atherosclerotic plaques exhibit remarkable plasticity, adopting multiple phenotypes that influence plaque development and stability. Single-cell studies have revealed that VSMCs can dedifferentiate, migrate, acquire macrophage-like characteristics, and produce extracellular matrix.
VSMC phenotypes identified in plaques include contractile cells (similar to normal VSMCs), synthetic cells (producing matrix), fibroblast-like cells, osteogenic cells (producing calcification), and macrophage-like cells (expressing macrophage markers and potentially contributing to foam cell formation). This plasticity explains conflicting reports on the origins of plaque cells and reveals potential targets for modulating plaque stability.
The factors that drive VSMC phenotype switching include lipid accumulation, inflammatory cytokines, mechanical stress, and oxidative stress. Single-cell studies have identified the transcription factors and epigenetic changes that establish specific VSMC phenotypes, revealing targets for preventing adverse phenotypic changes and promoting plaque stability.
5.3 Plaque Stability and Rupture
Plaque rupture, leading to thrombosis and acute cardiovascular events, is determined by plaque composition and cellular characteristics. Single-cell studies have identified cellular features that distinguish stable from unstable plaques, revealing potential biomarkers and therapeutic targets.
Stable plaques are characterized by thick fibrous caps composed of VSMCs and extracellular matrix, small necrotic cores, and limited inflammation. Single-cell analysis of stable plaques shows predominance of contractile VSMCs, reparative macrophages, and limited T cell infiltration.
Unstable plaques have thin fibrous caps, large necrotic cores, and intense inflammation. Single-cell analysis reveals expansion of inflammatory macrophages, cytotoxic T cells, and VSMCs with phenotypes that weaken the fibrous cap. These cells produce matrix-degrading enzymes and proinflammatory cytokines that promote plaque rupture.
Single-cell biomarkers that distinguish stable from unstable plaques could improve risk stratification and guide therapeutic decisions. The ability to identify high-risk plaques before rupture represents a major goal of cardiovascular research, with single-cell technologies providing new tools for achieving this goal.
6. Arrhythmias and Conduction Disorders
6.1 Cellular Basis of Arrhythmogenic Substrate
Cardiac arrhythmias, disturbances of the normal heart rhythm, are a major cause of morbidity and mortality in cardiovascular disease. Single-cell studies have revealed how cellular remodeling creates arrhythmogenic substrate, promoting abnormal impulse formation and conduction.
Fibrosis, a common feature of many cardiac diseases, creates electrical heterogeneity that promotes arrhythmias. Single-cell studies have revealed that myofibroblasts in fibrotic tissue couple to cardiomyocytes through gap junctions, altering conduction and promoting reentrant arrhythmias. The specific ion channels and connexins expressed by myofibroblasts have been identified through single-cell approaches, revealing targets for preventing arrhythmogenic fibroblast-cardiomyocyte interactions.
Cardiomyocytes in diseased hearts show altered expression of ion channels that disrupt normal electrical activity. Single-cell studies have identified specific ion channel subtypes that are downregulated or functionally altered in heart failure, myocardial infarction, and other conditions. These changes create heterogeneity in action potential duration and conduction velocity, promoting arrhythmias.
6.2 Pacemaker and Conduction System Cells
The specialized pacemaker and conduction system of the heart, responsible for initiating and propagating the cardiac impulse, has been characterized at single-cell resolution. These studies have revealed the molecular identity of pacemaker cells and the factors that establish automaticity and conduction.
Sinoatrial node cells express a distinctive set of ion channels including HCN channels (responsible for the funny current), calcium channels, and specific potassium channels that establish pacemaker activity. Single-cell studies have identified the transcription factors that establish this ion channel repertoire, revealing targets for creating biological pacemakers or enhancing pacemaker function.
Atrioventricular node and His-Purkinje system cells show distinctive gene expression patterns that establish slow conduction in the AV node (preventing atrioventricular reentry) and rapid conduction in the His-Purkinje system (coordinating ventricular activation). Single-cell studies have identified the molecular basis of these conduction properties, revealing targets for modulating conduction in disease states.
Diseases of the conduction system, including sick sinus syndrome and AV block, involve specific loss or dysfunction of specialized pacemaker and conduction cells. Single-cell studies have revealed the cellular basis of these diseases and potential strategies for regeneration or replacement of diseased cells.
7. Integration with Multi-Omics and Spatial Approaches
7.1 Single-Cell Multi-Omics in Cardiovascular Disease
The integration of multiple omics modalities from single cells has provided increasingly comprehensive views of cardiovascular biology and disease. scRNA-seq combined with ATAC-seq has revealed how epigenetic changes establish specific cell states in cardiovascular disease, identifying transcription factors and regulatory elements that could be targeted therapeutically.
Protein measurement combined with transcriptomics, through CITE-seq and related approaches, has validated cell type markers and revealed post-transcriptional regulation in cardiovascular cells. These approaches have been particularly valuable for characterizing cell surface proteins that could be targeted for drug delivery or cell isolation.
Metabolic profiling at single-cell resolution has revealed how metabolic reprogramming contributes to cardiovascular disease. Cardiomyocytes in failing hearts shift from fatty acid oxidation to glycolysis, a metabolic change that impairs efficiency and contributes to dysfunction. Targeting these metabolic adaptations represents an emerging therapeutic strategy.
7.2 Spatial Transcriptomics of Cardiac Tissue
The integration of spatial information with single-cell transcriptomics has revolutionized our understanding of cardiac tissue organization and cell-cell interactions. Spatial transcriptomics technologies including 10x Genomics Visium, NanoString GeoMx, and MERFISH have been applied to cardiac tissue, revealing how cellular neighborhoods influence disease processes.
Spatial transcriptomics has revealed the organization of cells around infarcts, with gradients of inflammatory, reparative, and fibrotic responses. Cells adjacent to the infarct show intense inflammatory activation, cells further away show reparative responses, and remote cells show minimal changes. This spatial organization creates distinct microenvironments that influence healing and remodeling.
In atherosclerotic plaques, spatial transcriptomics has revealed how different cell types are organized and interact within the plaque. Inflammatory cells cluster in the shoulder regions of plaques (areas prone to rupture), while smooth muscle cells and matrix are concentrated in the fibrous cap. This spatial organization influences plaque stability and rupture risk.
The integration of spatial data with single-cell reference datasets has enabled the deconvolution of spatial spots into constituent cell types, revealing how cell states vary with anatomical location and proximity to pathology. This integration has proven particularly valuable for understanding how microenvironment influences cellular responses in cardiovascular disease.
8. Precision Cardiology and Therapeutic Development
8.1 Single-Cell Biomarkers for Cardiovascular Disease
Single-cell discoveries are informing the development of novel biomarkers for cardiovascular disease diagnosis, prognosis, and therapeutic guidance. Cell type-specific markers identified through single-cell studies can be detected in blood or other accessible fluids, providing minimally invasive biomarkers that reflect specific cellular processes.
For example, markers of activated cardiac fibroblasts identified through single-cell studies can be detected in serum as biomarkers of active fibrosis, potentially guiding antifibrotic therapy. Similarly, markers of inflammatory macrophage subsets could serve as biomarkers of inflammatory activity, guiding anti-inflammatory therapy.
Single-cell signatures that predict disease progression or treatment response are being developed using machine learning approaches. These signatures incorporate information from multiple cell types and can predict outcomes such as heart failure development, arrhythmia risk, or response to specific therapies. The integration of single-cell data with clinical data is accelerating the development of precision cardiology approaches.
8.2 Cell-Specific Therapeutic Targeting
One of the most exciting implications of single-cell cardiovascular research is the potential for cell-specific therapeutic targeting. By identifying genes and pathways that are selectively expressed in disease-associated cell populations, single-cell approaches reveal targets that can be modulated to affect specific cell types while sparing others.
For example, fibroblast activation protein (FAP) is selectively expressed by activated cardiac fibroblasts but not by quiescent fibroblasts or other cell types. FAP-targeted therapies could selectively inhibit pathological fibrosis while sparing normal tissue repair. Similarly, specific markers of inflammatory macrophage subsets could enable targeted delivery of anti-inflammatory drugs to cells that drive pathology while sparing reparative macrophages.
Cell-specific targeting approaches being developed include antibody-drug conjugates, cell-specific promoters for gene therapy, and ligand-targeted nanoparticles. These approaches promise to increase therapeutic efficacy while reducing side effects, representing a new paradigm for cardiovascular drug development.
8.3 Regenerative Medicine and Cell Therapy
Single-cell technologies are accelerating progress in cardiac regenerative medicine and cell therapy. The identification of cardiac progenitor cell populations, characterization of developmental pathways, and understanding of barriers to regeneration have all been advanced through single-cell approaches.
Direct cardiac reprogramming, in which fibroblasts are converted to cardiomyocytes by transcription factor overexpression, has been informed by single-cell characterization of the intermediate states and regulatory networks involved. Single-cell studies have identified optimal combinations of transcription factors and small molecules that enhance reprogramming efficiency and maturity.
Cell therapy approaches using stem cell-derived cardiomyocytes are being optimized based on single-cell characterization of differentiation protocols. scRNA-seq is used to assess the maturity and purity of differentiated cells, identify remaining undifferentiated cells that could form teratomas, and optimize differentiation conditions for therapeutic cell production.
9. Future Directions
9.1 Longitudinal Single-Cell Studies
Cross-sectional single-cell studies have provided invaluable insights into cardiovascular disease, but longitudinal studies that track cellular changes over time within individuals are needed to understand disease progression and identify early intervention points. Emerging technologies for serial sampling, including liquid biopsy approaches that capture circulating cardiac cells or cell-free RNA, are enabling longitudinal single-cell studies.
Longitudinal single-cell studies will be particularly valuable for understanding the transition from compensated hypertrophy to heart failure, the progression of atherosclerosis, and the development of arrhythmogenic substrate. These studies will identify cellular changes that precede clinical decompensation, providing opportunities for early intervention.
9.2 Integration with Clinical Data and Genetics
The integration of single-cell data with clinical phenotypes, imaging data, and genetic information is accelerating the translation of basic discoveries into clinical applications. Genetic variants associated with cardiovascular disease can be mapped to specific cell types based on their expression patterns, revealing mechanisms and potential therapeutic targets.
Integration with imaging data, including cardiac MRI and CT angiography, enables correlation of cellular features with clinical parameters of cardiac function and plaque characteristics. These correlations will improve our understanding of how cellular changes manifest in clinically detectable phenotypes and will identify cellular biomarkers that can be measured noninvasively.
9.3 Human Cardiac Cell Atlas
Ongoing efforts to generate comprehensive single-cell atlases of the human heart, including healthy individuals and patients with various cardiovascular diseases, will provide invaluable resources for future research. These atlases will define the complete cellular diversity of the human heart, establish reference datasets for comparison, and identify cellular features associated with disease states.
The Human Cell Atlas and other international consortia are making significant progress toward this goal, with single-cell datasets from thousands of human hearts already available. The integration of these datasets with clinical and genetic data will transform our understanding of cardiovascular disease and enable precision cardiology approaches.
10. Conclusion
Single-cell RNA sequencing has transformed our understanding of cardiovascular biology and disease, revealing remarkable cellular diversity that was previously unrecognized. From the comprehensive characterization of cardiac cell types to the elucidation of disease mechanisms and identification of novel therapeutic targets, single-cell approaches have accelerated progress in virtually every area of cardiovascular research.
The discoveries enabled by single-cell technologies are already translating into clinical applications. Novel biomarkers based on cell-specific signatures are being developed for diagnosis and prognosis. Cell-specific therapeutic targeting approaches are advancing through preclinical and early clinical development. Regenerative medicine approaches informed by single-cell characterization are moving toward clinical application.
As single-cell technologies continue to evolve, integrating multiple omics modalities, preserving spatial context, and enabling longitudinal analysis, they promise to further accelerate cardiovascular research and clinical translation. The next decade of single-cell cardiovascular research will likely witness the maturation of precision cardiology, in which cellular profiling guides diagnosis, prognosis, and therapy selection for individual patients.
The single-cell revolution in cardiovascular research exemplifies how technological innovation can transform our understanding of complex biological systems and accelerate the development of novel therapies. By revealing the heart at single-cell resolution, these technologies have opened new windows into cardiac biology and new pathways toward effective treatments for cardiovascular disease.
Acknowledgments
The authors acknowledge the contributions of the cardiovascular research community whose single-cell studies have transformed our understanding of heart disease. We thank the many researchers who have openly shared their data, methods, and insights, accelerating progress toward better treatments for cardiovascular disease.
References
[Note: Key references include seminal single-cell atlases of the heart by Litviňuková et al. (2020), Skelly et al. (2018), and others; studies of cardiac macrophages by Epelman et al. and others; investigations of fibroblast heterogeneity by Ruiz-Villalba et al., Kaur et al., and others; and numerous subsequent studies applying single-cell technologies to specific cardiovascular diseases.]
Word Count: 6,912 words
Authors: Tom and Spike
Date: March 2026